Genotyping on ctDNA Identifies Shifts in Mutation Spectrum Between Newly Diagnosed and Relapse/Refractory DLBCL

Overview of attention for article published in OncoTargets and therapy, October 2020

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age and source (62nd percentile)

Mentioned by

twitter: 3 X users

Citations

dimensions_citation: 9 Dimensions

Readers on

mendeley: 16 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 3 X posts from 3 X users, with an upper bound of 3,546 followers.

Genotyping on ctDNA Identifies Shifts in Mutation Spectrum Between Newly Diagnosed and Relapse/Refractory DLBCL. #lymphoma #lymsm https://t.co/QWK3PjS4TS

01 Nov 2020

Reply Repost Favourite

PubMed_ Genotyping on ctDNA Identifies Shifts in Mutation Spectrum Between Newly Diagnosed and Relapse/Refractory DLBCL. https://t.co/LdkvB378vt

31 Oct 2020

Reply Repost Favourite

New article: Genotyping on ctDNA Identifies Shifts in Mutation Spectrum Between Newly Diagnosed and Relapse/Refractory DLBCL. https://t.co/BqZptPS0pL #DLBCL #lymsm #hematology https://t.co/xSrLJBCMPx

31 Oct 2020

Reply Repost Favourite

Dove Medical Press

Article Metrics

Genotyping on ctDNA Identifies Shifts in Mutation Spectrum Between Newly Diagnosed and Relapse/Refractory DLBCL

About this Attention Score

Mentioned by

Citations

Readers on